Basic | |
---|---|
Market Cap | $1.86M |
Price | $0.91 |
52 Week Range | 0.373-9.5 |
Beta | 1.61 |
Margins | |
Gross Profit Margin | -6.18% |
Operating Profit Margin | -2590.04% |
Net Profit Margin | -1764.74% |
Valuation (TTM) | |
P/E Ratio | -0.38 |
Price to Sales Ratio | 6.76 |
Price to Book Ratio | 0.90 |
PEG Ratio | -0.01 |
Medical - Devices
Healthcare
22
2014-06-27T00:00:00.000Z
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
215 944 6100
642 Newtown Yardley Road, Newtown, PA, 18940, US
0001610853